Assessing Neurocrine Biosciences (NBIX) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Neurocrine Biosciences, Inc. (NBIX)
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
neurocrine.com/about-us/webcasts-presentations
Company Research
Source: Yahoo! Finance
Neurocrine Biosciences (NBIX) has drawn fresh attention after a solid run, with the stock showing gains over the past week, month, and past 3 months alongside positive recent total return figures. See our latest analysis for Neurocrine Biosciences. With the share price at US$167.35, the stock has strong recent momentum, including a 23.91% 1 month share price return and 34.30% 1 year total shareholder return. The 77.98% 3 year total shareholder return points to a solid longer term record. If Neurocrine Biosciences has you rethinking what is possible in healthcare, this is a good moment to scan other opportunities across AI driven drug discovery and treatment via 40 healthcare AI stocks With Neurocrine Biosciences now at US$167.35 after strong recent returns and an indicated 62% intrinsic discount, the key question is whether the stock still offers value or whether the market is already pricing in future growth. Most Popular Narrative: 10.2% Undervalued Against the last clo
Show less
Read more
Impact Snapshot
Event Time:
NBIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NBIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NBIX alerts
High impacting Neurocrine Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
NBIX
News
- Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results [Yahoo! Finance]Yahoo! Finance
- Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial ResultsPR Newswire
- Neurocrine Biosciences (NBIX) Stock Looks Fair On Earnings But Pricey Versus Biotechs [Yahoo! Finance]Yahoo! Finance
- Neurocrine Biosciences (NBIX) Could Be 8% Undervalued Following New Phase 2 Study [Yahoo! Finance]Yahoo! Finance
- Tardive Dyskinesia Market to Grow Rapidly at a CAGR of 8.1% During the Forecast Period (2026-2036) | DelveInsight [Yahoo! Finance]Yahoo! Finance
NBIX
Earnings
- 5/5/26 - Beat
NBIX
Sec Filings
- 7/10/26 - Form 144
- 7/9/26 - Form 4
- 7/9/26 - Form 144
- NBIX's page on the SEC website